{"id":"https://openalex.org/W4283699223","doi":"https://doi.org/10.1016/j.xkme.2022.100512","title":"Efficacy of Difelikefalin for the Treatment of Moderate to Severe Pruritus in Hemodialysis Patients: Pooled Analysis of KALM-1 and KALM-2 Phase 3 Studies","display_name":"Efficacy of Difelikefalin for the Treatment of Moderate to Severe Pruritus in Hemodialysis Patients: Pooled Analysis of KALM-1 and KALM-2 Phase 3 Studies","publication_year":2022,"publication_date":"2022-06-28","ids":{"openalex":"https://openalex.org/W4283699223","doi":"https://doi.org/10.1016/j.xkme.2022.100512","pmid":"https://pubmed.ncbi.nlm.nih.gov/36016762","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/9396406"},"language":"en","primary_location":{"id":"doi:10.1016/j.xkme.2022.100512","doi":"https://doi.org/10.1016/j.xkme.2022.100512","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.xkme.2022.100512","pdf_url":"http://www.kidneymedicinejournal.org/article/S2590059522001339/pdf","source":{"id":"https://openalex.org/S4210206143","display_name":"Kidney Medicine","issn_l":"2590-0595","issn":["2590-0595"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","jufo-1","ki-jl-1","norway-1","oarl","poland-20"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Kidney Medicine","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"http://www.kidneymedicinejournal.org/article/S2590059522001339/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5082839554","display_name":"Joel Michels Topf","orcid":"https://orcid.org/0000-0002-4697-7787","observed_orcids":["https://orcid.org/0000-0002-4697-7787"]},"institutions":[{"id":"https://openalex.org/I177721651","display_name":"Oakland University","ror":"https://ror.org/01ythxj32","country_code":"US","type":"education","lineage":["https://openalex.org/I177721651"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joel Topf","raw_affiliation_strings":["Oakland University William Beaumont School of Medicine, Auburn Hills, Michigan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oakland University William Beaumont School of Medicine, Auburn Hills, Michigan","institution_ids":["https://openalex.org/I177721651"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000648597","display_name":"Thomas D. Wooldridge","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Thomas Wooldridge","raw_affiliation_strings":["Nephrology and Hypertension Associates, Ltd, Tupelo, Mississippi"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Nephrology and Hypertension Associates, Ltd, Tupelo, Mississippi","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027355791","display_name":"Kieran McCafferty","orcid":"https://orcid.org/0000-0002-0762-2270","observed_orcids":["https://orcid.org/0000-0002-0762-2270"]},"institutions":[{"id":"https://openalex.org/I225661044","display_name":"Barts Health NHS Trust","ror":"https://ror.org/00b31g692","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I225661044"]},{"id":"https://openalex.org/I2801259928","display_name":"Royal London Hospital","ror":"https://ror.org/019my5047","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I225661044","https://openalex.org/I2801259928"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Kieran McCafferty","raw_affiliation_strings":["The Royal London Hospital-Barts Health NHS Trust, London, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Royal London Hospital-Barts Health NHS Trust, London, United Kingdom","institution_ids":["https://openalex.org/I225661044","https://openalex.org/I2801259928"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051347157","display_name":"Michael Sch\u00f6mig","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210108846","display_name":"Nierenzentrum Heidelberg","ror":"https://ror.org/01nwbp351","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210108846"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Michael Sch\u00f6mig","raw_affiliation_strings":["Dialysezentrum Heilbronn, Heilbronn, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dialysezentrum Heilbronn, Heilbronn, Germany","institution_ids":["https://openalex.org/I4210108846"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020754061","display_name":"Botond Szabolcs Csiky","orcid":"https://orcid.org/0000-0003-1123-135X","observed_orcids":["https://orcid.org/0000-0003-1123-135X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Botond Csiky","raw_affiliation_strings":["Fresenius Medical Care Szatellita Dialysis Center Pecs, Pecs, Hungary"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fresenius Medical Care Szatellita Dialysis Center Pecs, Pecs, Hungary","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037222557","display_name":"Rafa\u0142 Zwiech","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210122071","display_name":"Medical University of Lodz","ror":"https://ror.org/02t4ekc95","country_code":"PL","type":"education","lineage":["https://openalex.org/I4210122071"]}],"countries":["PL"],"is_corresponding":false,"raw_author_name":"Rafal Zwiech","raw_affiliation_strings":["Norbert Barlicki Memorial Teaching Hospital No. 1 of the Medical University of Lodz, Lodz, Poland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Norbert Barlicki Memorial Teaching Hospital No. 1 of the Medical University of Lodz, Lodz, Poland","institution_ids":["https://openalex.org/I4210122071"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081989739","display_name":"Warren Wen","orcid":"https://orcid.org/0009-0009-2128-3832","observed_orcids":["https://orcid.org/0009-0009-2128-3832"]},"institutions":[{"id":"https://openalex.org/I4210141518","display_name":"Cara Therapeutics (United States)","ror":"https://ror.org/057w5q630","country_code":"US","type":"company","lineage":["https://openalex.org/I4210141518"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Warren Wen","raw_affiliation_strings":["Cara Therapeutics, Stamford, CT"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cara Therapeutics, Stamford, CT","institution_ids":["https://openalex.org/I4210141518"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053157314","display_name":"Sarbani Bhaduri","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sarbani Bhaduri","raw_affiliation_strings":["Bhaduri Biotech Consulting, El Paso, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bhaduri Biotech Consulting, El Paso, TX","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038302780","display_name":"Catherine L. Munera","orcid":"https://orcid.org/0009-0000-7862-8576","observed_orcids":["https://orcid.org/0009-0000-7862-8576"]},"institutions":[{"id":"https://openalex.org/I4210141518","display_name":"Cara Therapeutics (United States)","ror":"https://ror.org/057w5q630","country_code":"US","type":"company","lineage":["https://openalex.org/I4210141518"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Catherine Munera","raw_affiliation_strings":["Cara Therapeutics, Stamford, CT"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cara Therapeutics, Stamford, CT","institution_ids":["https://openalex.org/I4210141518"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034744787","display_name":"Rong Lin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210157459","display_name":"Biostatistical Consulting (United States)","ror":"https://ror.org/05p8v7d26","country_code":"US","type":"company","lineage":["https://openalex.org/I4210157459"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rong Lin","raw_affiliation_strings":["Biostatistical Consulting Inc, Lexington, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biostatistical Consulting Inc, Lexington, MA","institution_ids":["https://openalex.org/I4210157459"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070155999","display_name":"Alia Jebara","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210141518","display_name":"Cara Therapeutics (United States)","ror":"https://ror.org/057w5q630","country_code":"US","type":"company","lineage":["https://openalex.org/I4210141518"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alia Jebara","raw_affiliation_strings":["Cara Therapeutics, Stamford, CT"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cara Therapeutics, Stamford, CT","institution_ids":["https://openalex.org/I4210141518"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108894040","display_name":"Joshua Cirulli","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210141518","display_name":"Cara Therapeutics (United States)","ror":"https://ror.org/057w5q630","country_code":"US","type":"company","lineage":["https://openalex.org/I4210141518"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joshua Cirulli","raw_affiliation_strings":["Cara Therapeutics, Stamford, CT"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cara Therapeutics, Stamford, CT","institution_ids":["https://openalex.org/I4210141518"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5075110399","display_name":"Fr\u00e9d\u00e9rique Menzaghi","orcid":"https://orcid.org/0000-0002-3584-1665","observed_orcids":["https://orcid.org/0000-0002-3584-1665"]},"institutions":[{"id":"https://openalex.org/I4210141518","display_name":"Cara Therapeutics (United States)","ror":"https://ror.org/057w5q630","country_code":"US","type":"company","lineage":["https://openalex.org/I4210141518"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Fr\u00e9d\u00e9rique Menzaghi","raw_affiliation_strings":["Cara Therapeutics, Stamford, CT"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cara Therapeutics, Stamford, CT","institution_ids":["https://openalex.org/I4210141518"]}]}],"institutions":[],"countries_distinct_count":4,"institutions_distinct_count":7,"corresponding_author_ids":["https://openalex.org/A5075110399"],"corresponding_institution_ids":["https://openalex.org/I4210141518"],"apc_list":{"value":2400,"currency":"USD","value_usd":2400},"apc_paid":{"value":2400,"currency":"USD","value_usd":2400},"fwci":14.1918,"has_fulltext":true,"cited_by_count":106,"citation_normalized_percentile":{"value":0.99604975,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":96,"max":100},"biblio":{"volume":"4","issue":"8","first_page":"100512","last_page":"100512"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10291","display_name":"Dialysis and Renal Disease Management","score":0.6625999808311462,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10291","display_name":"Dialysis and Renal Disease Management","score":0.6625999808311462,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10837","display_name":"Dermatology and Skin Diseases","score":0.3237000107765198,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10196","display_name":"Pain Mechanisms and Treatments","score":0.0007999999797903001,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/difelikefalin","display_name":"difelikefalin","score":0.9980000257492065},{"id":"https://openalex.org/keywords/chronic-kidney-disease-associated-pruritus","display_name":"chronic kidney disease-associated pruritus","score":0.9589999914169312},{"id":"https://openalex.org/keywords/hemodialysis","display_name":"hemodialysis","score":0.9419999718666077},{"id":"https://openalex.org/keywords/kappa-opioid-receptor-agonists","display_name":"kappa opioid receptor agonists","score":0.906000018119812},{"id":"https://openalex.org/keywords/itch-intensity","display_name":"itch severity","score":0.6660000085830688},{"id":"https://openalex.org/keywords/gabapentin","display_name":"gabapentin","score":0.5989999771118164},{"id":"https://openalex.org/keywords/pregabalin","display_name":"pregabalin","score":0.996999979019165},{"id":"https://openalex.org/keywords/subgroup-analysis","display_name":"subgroup analysis","score":0.5740000009536743},{"id":"https://openalex.org/keywords/intravenous-drug-delivery","display_name":"intravenous drug delivery","score":0.47600001096725464},{"id":"https://openalex.org/keywords/end-stage-renal-disease","display_name":"end-stage renal disease","score":0.5580000281333923}],"concepts":[{"id":"https://openalex.org/C2778063415","wikidata":"https://www.wikidata.org/wiki/Q391744","display_name":"Hemodialysis","level":2,"score":0.7654221653938293},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6593492031097412},{"id":"https://openalex.org/C3017906399","wikidata":"https://www.wikidata.org/wiki/Q48973845","display_name":"Pooled analysis","level":3,"score":0.5368154048919678},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4843519926071167},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.44623100757598877},{"id":"https://openalex.org/C44280652","wikidata":"https://www.wikidata.org/wiki/Q104837","display_name":"Phase (matter)","level":2,"score":0.41093334555625916},{"id":"https://openalex.org/C95190672","wikidata":"https://www.wikidata.org/wiki/Q815382","display_name":"Meta-analysis","level":2,"score":0.33527350425720215},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.06054264307022095},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.0}],"mesh":[],"locations_count":4,"locations":[{"id":"doi:10.1016/j.xkme.2022.100512","doi":"https://doi.org/10.1016/j.xkme.2022.100512","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.xkme.2022.100512","pdf_url":"http://www.kidneymedicinejournal.org/article/S2590059522001339/pdf","source":{"id":"https://openalex.org/S4210206143","display_name":"Kidney Medicine","issn_l":"2590-0595","issn":["2590-0595"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","jufo-1","ki-jl-1","norway-1","oarl","poland-20"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Kidney Medicine","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:9396406","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/9396406","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Kidney Med","raw_type":"Text"},{"id":"pmid:36016762","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/36016762","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Kidney medicine","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:5fb7b3df14f54a62a57229d07fedc475","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/5fb7b3df14f54a62a57229d07fedc475","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Kidney Medicine, Vol 4, Iss 8, Pp 100512- (2022)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1016/j.xkme.2022.100512","doi":"https://doi.org/10.1016/j.xkme.2022.100512","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.xkme.2022.100512","pdf_url":"http://www.kidneymedicinejournal.org/article/S2590059522001339/pdf","source":{"id":"https://openalex.org/S4210206143","display_name":"Kidney Medicine","issn_l":"2590-0595","issn":["2590-0595"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","jufo-1","ki-jl-1","norway-1","oarl","poland-20"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Kidney Medicine","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[{"id":"https://openalex.org/G2253357373","display_name":null,"funder_award_id":"MGD&U0002","funder_id":"https://openalex.org/F4320315977","funder_display_name":"Barts Charity"}],"funders":[{"id":"https://openalex.org/F4320307770","display_name":"AstraZeneca","ror":"https://ror.org/04r9x1a08"},{"id":"https://openalex.org/F4320315053","display_name":"Acorda Therapeutics","ror":"https://ror.org/01788sq40"},{"id":"https://openalex.org/F4320315977","display_name":"Barts Charity","ror":"https://ror.org/0513pp416"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4283699223.pdf","grobid_xml":"https://content.openalex.org/works/W4283699223.grobid-xml"},"referenced_works_count":22,"referenced_works":["https://openalex.org/W1579314656","https://openalex.org/W1976506153","https://openalex.org/W2002740652","https://openalex.org/W2060581001","https://openalex.org/W2130281254","https://openalex.org/W2149614842","https://openalex.org/W2416880829","https://openalex.org/W2524051065","https://openalex.org/W2735601046","https://openalex.org/W2749503721","https://openalex.org/W2783223403","https://openalex.org/W2806922111","https://openalex.org/W2912717193","https://openalex.org/W2942552977","https://openalex.org/W2962688070","https://openalex.org/W2988468898","https://openalex.org/W3037885651","https://openalex.org/W3045554752","https://openalex.org/W3108155642","https://openalex.org/W4200271586","https://openalex.org/W4283701013","https://openalex.org/W4397000969"],"related_works":["https://openalex.org/W4292841587","https://openalex.org/W4397000969","https://openalex.org/W4228996739","https://openalex.org/W4396990020","https://openalex.org/W2988468898","https://openalex.org/W4415425509","https://openalex.org/W4398235663","https://openalex.org/W4408883519","https://openalex.org/W4390706715","https://openalex.org/W7128201396"],"abstract_inverted_index":{"Rationale":[0],"&":[1,82],"Objective":[2],"Chronic":[3],"kidney":[4],"disease\u2013associated":[5],"pruritus":[6],"(CKD-aP)":[7],"in":[8,30,46,93,182,260,286],"patients":[9,31,290],"treated":[10,90,291],"by":[11,49,76,91,292],"hemodialysis":[12],"(HD)":[13],"impairs":[14],"quality":[15],"of":[16,28,150,163,193,264,275,289],"life":[17],"(QoL).":[18],"Difelikefalin,":[19],"a":[20,77],"selective":[21],"\u03ba-opioid":[22],"receptor":[23],"agonist,":[24],"decreased":[25],"the":[26,41,98,191,215,227,272,308],"intensity":[27,111,181],"CKD-aP":[29,89],"undergoing":[32],"HD.":[33,293],"This":[34,136],"pooled":[35,137],"analysis":[36,138],"evaluated":[37],"difelikefalin's":[38],"efficacy":[39],"and":[40,45,58,97,119,123,197,254,307],"itch-related":[42,120],"QoL":[43,121],"overall":[44],"subgroups":[47,183],"defined":[48],"demographics":[50],"or":[51,68,107,199],"disease":[52],"characteristics.":[53],"Study":[54],"Design":[55],"In":[56],"KALM-1":[57,301],"KALM-2,":[59],"participants":[60,129,203],"were":[61,130,249],"randomized":[62,131],"(1:1)":[63],"to":[64,87,243],"receive":[65],"intravenous":[66],"difelikefalin":[67,103,144,155,171,205],"placebo":[69,158,174,207],"3":[70],"times/wk":[71],"for":[72],"12":[73],"weeks,":[74],"followed":[75],"52-week":[78],"open-label":[79],"extension.":[80],"Setting":[81],"Participants":[83],"Adults":[84],"with":[85,146,154,170,237,283],"moderate":[86],"severe":[88],"HD":[92],"North":[94],"America,":[95],"Europe,":[96],"Asia-Pacific":[99],"region.":[100],"Intervention":[101],"Intravenous":[102],"at":[104],"0.5":[105],"mcg/kg":[106],"placebo.":[108],"Outcomes":[109],"Itch":[110,125,229,240,256],"(Worst":[112],"Itching":[113],"Intensity":[114],"Numerical":[115],"Rating":[116],"Scale":[117],"[WI-NRS])":[118],"(Skindex-10":[122],"5-D":[124,228,239,255],"questionnaires).":[126],"Results":[127],"851":[128],"(difelikefalin,":[132],"n=426;":[133],"placebo,":[134],"n=425).":[135],"demonstrated":[139,279],"early":[140],"(week":[141],"1),":[142],"sustained":[143,238,281],"efficacy,":[145,282],"significantly":[147,168],"greater":[148,169],"achievement":[149],"\u22653-point":[151],"WI-NRS":[152,165],"reduction":[153,166],"(51.1%)":[156],"versus":[157,173,206],"(35.2%;":[159],"P":[160,176,222,235],"<0.001).":[161,177],"Achievement":[162],"a\u22654-point":[164],"was":[167],"(38.7%)":[172],"(23.4%;":[175],"Difelikefalin":[178,278],"reduced":[179],"itch":[180],"based":[184],"on":[185,214,226],"age,":[186],"sex,":[187],"anti-itch":[188],"medication":[189],"use,":[190],"presence":[192],"specific":[194],"medical":[195],"conditions,":[196],"gabapentin":[198],"pregabalin":[200],"use.":[201],"More":[202],"receiving":[204],"achieved":[208],"clinically":[209],"meaningful":[210],"decreases":[211],"of\u226515":[212],"points":[213,225],"Skindex-10":[216],"scale":[217,230],"(55.5%":[218],"vs":[219,232],"40.5%,":[220],"respectively;":[221,234],"<0.001)":[223],"and\u22655":[224],"(52.1%":[231],"42.3%,":[233],"=0.01),":[236],"effects":[241],"up":[242],"64":[244],"weeks.":[245],"Limitations":[246],"Subgroup":[247],"samples":[248],"small.":[250],"The":[251,300],"WI-NRS,":[252],"Skindex-10,":[253],"are":[257],"not":[258,270],"used":[259],"routine":[261],"clinical":[262],"care":[263],"dialysis":[265],"patients;":[266],"therefore,":[267],"findings":[268],"may":[269],"reflect":[271],"real-world":[273],"effectiveness":[274],"difelikefalin.":[276],"Conclusions":[277],"rapid,":[280],"consistent":[284],"results":[285],"diverse":[287],"populations":[288],"Funding":[294],"Cara":[295],"Therapeutics,":[296],"Inc.":[297],"Trial":[298],"Registration":[299],"trial":[302,310],"is":[303,311],"registered":[304,312],"as":[305,313],"NCT03422653":[306],"KALM-2":[309],"NCT03636269.":[314]},"counts_by_year":[{"year":2026,"cited_by_count":18},{"year":2025,"cited_by_count":30},{"year":2024,"cited_by_count":34},{"year":2023,"cited_by_count":20},{"year":2022,"cited_by_count":4}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2022-06-30T00:00:00"}